Carta científica
Peritonitis esclerosante encapsulada en un paciente en tratamiento con atenolol
Sclerosing encapsulating peritonitis in a patient being treated with atenolol
S. Santos-Magadán
, M. Chiva-de-Agustín
Autor para correspondencia
Servicio de Diagnóstico por Imagen, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, España
Leído
2742
Vecesse ha leído el artículo
970
Total PDF
1772
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 2 | 0 | 2 |
| 2025 11 | 0 | 7 | 7 |
| 2025 10 | 3 | 9 | 12 |
| 2025 9 | 3 | 5 | 8 |
| 2025 8 | 3 | 5 | 8 |
| 2025 7 | 3 | 0 | 3 |
| 2025 6 | 0 | 2 | 2 |
| 2025 5 | 0 | 3 | 3 |
| 2025 4 | 7 | 2 | 9 |
| 2025 3 | 6 | 5 | 11 |
| 2025 2 | 3 | 2 | 5 |
| 2025 1 | 2 | 7 | 9 |
| 2024 12 | 0 | 4 | 4 |
| 2024 11 | 2 | 2 | 4 |
| 2024 10 | 0 | 4 | 4 |
| 2024 9 | 1 | 2 | 3 |
| 2024 8 | 1 | 2 | 3 |
| 2024 7 | 0 | 2 | 2 |
| 2024 6 | 4 | 4 | 8 |
| 2024 5 | 0 | 2 | 2 |
| 2024 4 | 1 | 2 | 3 |
| 2024 3 | 0 | 9 | 9 |
| 2024 2 | 0 | 15 | 15 |
| 2024 1 | 1 | 2 | 3 |
| 2023 12 | 0 | 6 | 6 |
| 2023 11 | 1 | 7 | 8 |
| 2023 10 | 2 | 10 | 12 |
| 2023 9 | 0 | 9 | 9 |
| 2023 8 | 1 | 9 | 10 |
| 2023 7 | 0 | 17 | 17 |
| 2023 6 | 0 | 12 | 12 |
| 2023 5 | 0 | 5 | 5 |
| 2023 4 | 0 | 2 | 2 |
| 2023 3 | 0 | 1 | 1 |
| 2023 2 | 1 | 5 | 6 |
| 2022 1 | 1 | 4 | 5 |
| 2022 12 | 0 | 5 | 5 |
| 2022 11 | 0 | 4 | 4 |
| 2022 10 | 2 | 4 | 6 |
| 2022 9 | 0 | 8 | 8 |
| 2022 8 | 0 | 16 | 16 |
| 2022 7 | 0 | 5 | 5 |
| 2022 6 | 0 | 2 | 2 |
| 2022 5 | 0 | 5 | 5 |
| 2022 4 | 0 | 3 | 3 |
| 2022 3 | 0 | 12 | 12 |
| 2022 2 | 0 | 10 | 10 |
| 2021 1 | 0 | 17 | 17 |
| 2021 12 | 0 | 13 | 13 |
| 2021 11 | 0 | 11 | 11 |
| 2021 10 | 0 | 17 | 17 |
| 2021 9 | 0 | 15 | 15 |
| 2021 8 | 0 | 11 | 11 |
| 2021 7 | 0 | 8 | 8 |
| 2021 6 | 0 | 2 | 2 |
| 2021 5 | 0 | 11 | 11 |
| 2021 4 | 0 | 25 | 25 |
| 2021 3 | 0 | 19 | 19 |
| 2021 2 | 0 | 11 | 11 |
| 2020 1 | 0 | 10 | 10 |
| 2020 12 | 0 | 4 | 4 |
| 2020 11 | 0 | 4 | 4 |
| 2020 10 | 0 | 5 | 5 |
| 2020 9 | 0 | 2 | 2 |
| 2020 8 | 2 | 8 | 10 |
| 2020 7 | 0 | 3 | 3 |
| 2020 6 | 0 | 2 | 2 |
| 2020 5 | 3 | 6 | 9 |
| 2020 4 | 0 | 3 | 3 |
| 2020 3 | 0 | 8 | 8 |
| 2020 2 | 0 | 3 | 3 |
| 2020 1 | 0 | 1 | 1 |
| 2019 12 | 0 | 4 | 4 |
| 2019 11 | 1 | 2 | 3 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 0 | 4 | 4 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 3 | 3 |
| 2019 5 | 1 | 7 | 8 |
| 2019 3 | 0 | 2 | 2 |
| 2019 2 | 0 | 1 | 1 |
| 2018 12 | 0 | 1 | 1 |
| 2018 11 | 0 | 1 | 1 |
| 2018 10 | 0 | 1 | 1 |
| 2018 5 | 21 | 2 | 23 |
| 2018 4 | 61 | 4 | 65 |
| 2018 3 | 47 | 2 | 49 |
| 2018 2 | 36 | 4 | 40 |
| 2018 1 | 44 | 8 | 52 |
| 2017 12 | 47 | 4 | 51 |
| 2017 11 | 44 | 4 | 48 |
| 2017 10 | 45 | 9 | 54 |
| 2017 9 | 50 | 10 | 60 |
| 2017 8 | 48 | 8 | 56 |
| 2017 7 | 64 | 11 | 75 |
| 2017 6 | 46 | 18 | 64 |
| 2017 5 | 59 | 24 | 83 |
| 2017 4 | 36 | 10 | 46 |
| 2017 3 | 57 | 25 | 82 |
| 2017 2 | 103 | 20 | 123 |
| 2016 1 | 74 | 15 | 89 |
| 2016 12 | 77 | 12 | 89 |
| 2016 11 | 76 | 13 | 89 |
| 2016 10 | 135 | 20 | 155 |
| 2016 9 | 133 | 11 | 144 |
| 2016 8 | 38 | 9 | 47 |
| 2016 7 | 51 | 3 | 54 |
| 2016 6 | 44 | 25 | 69 |
| 2016 5 | 31 | 27 | 58 |
| 2016 4 | 35 | 16 | 51 |
| 2016 3 | 45 | 20 | 65 |
| 2016 2 | 37 | 18 | 55 |
| 2015 1 | 28 | 19 | 47 |
| 2015 12 | 28 | 19 | 47 |
| 2015 11 | 22 | 15 | 37 |
| 2015 10 | 2 | 5 | 7 |
| 2015 9 | 0 | 5 | 5 |
| 2015 8 | 1 | 5 | 6 |
| 2015 7 | 0 | 4 | 4 |
| 2015 6 | 0 | 5 | 5 |
| 2015 5 | 0 | 4 | 4 |
| 2015 4 | 2 | 0 | 2 |
| 2015 3 | 12 | 3 | 15 |
| 2015 2 | 12 | 1 | 13 |
| 2015 1 | 10 | 8 | 18 |
| 2014 12 | 8 | 10 | 18 |
| 2014 11 | 6 | 9 | 15 |
Mostrar todo
